Loading…
Reported covered position: Intern, Rep. Bunning/Sen. McConnell 1995
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Generating Antibiotic Incentives Now Act of 2010
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
Generating Antibiotic Incentives Now Act of 2010
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · 4A
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
Source: Senate LDA
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Indian Health Care Improvement Reauthorization and Extension Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology
Financial Services and General Government Appropriations Act, 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
Financial Services and General Government Appropriations Act, 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology
Community-Based Mental Health Infrastructure Improvements Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
Community-Based Mental Health Infrastructure Improvements Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · Q4
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · third_quarter · Q3
HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE